Nuveen Asset Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 147,875 shares of RYTM stock, worth $8.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,875

Previous 149,119 0.83%

Holding current value

$8.86 Million

Previous $6.12 Million 26.54%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $50,767 - $68,420	-1,244 Reduced 0.83%	147,875 $7.75 Million
Q2 2024 Aug 09, 2024	BUY	$35.41 - $44.37 $226,057 - $283,258	6,384 Added 4.47%	149,119 $6.12 Million
Q1 2024 May 13, 2024	SELL	$39.12 - $52.44 $36,538 - $48,978	-934 Reduced 0.65%	142,735 $6.18 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $44,576 - $103,449	2,084 Added 1.47%	143,669 $6.6 Million
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $898,924 - $1.58 Million	-56,858 Reduced 28.65%	141,585 $3.25 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $2.43 Million - $3.15 Million	149,039 Added 301.67%	198,443 $3.27 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $32,291 - $65,501	1,913 Added 4.03%	49,404 $881,000
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $159,934 - $217,830	7,201 Added 17.87%	47,491 $1.38 Million
Q3 2022 Nov 14, 2022	SELL	$4.3 - $30.85 $3,934 - $28,227	-915 Reduced 2.22%	40,290 $987,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $495,284 - $1.94 Million	-158,745 Reduced 79.39%	41,205 $171,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $14,883 - $29,718	-2,428 Reduced 1.2%	199,950 $2.25 Million
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $100,026 - $161,295	-11,604 Reduced 5.42%	202,378 $2.02 Million
Q3 2021 Nov 12, 2021	SELL	$11.68 - $20.72 $423,680 - $751,597	-36,274 Reduced 14.49%	213,982 $2.79 Million
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $1.8 Million - $2.19 Million	96,987 Added 63.28%	250,256 $4.9 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $367,800 - $717,256	18,163 Added 13.44%	153,269 $3.26 Million
Q4 2020 May 17, 2021	SELL	$21.17 - $32.61 $323,265 - $497,954	-15,270 Reduced 10.15%	135,106 $4.02 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $650,278 - $1 Million	30,717 Added 25.67%	150,376 $4.47 Million
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $34,120 - $57,608	1,882 Added 1.6%	119,659 $2.59 Million
Q2 2020 Aug 14, 2020	BUY	$14.41 - $25.35 $161,118 - $283,438	11,181 Added 10.49%	117,777 $2.63 Million
Q1 2020 May 14, 2020	BUY	$13.16 - $22.9 $90,211 - $156,979	6,855 Added 6.87%	106,596 $1.62 Million
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $508,268 - $663,637	26,025 Added 35.3%	99,741 $2.29 Million
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $64,592 - $85,025	-3,469 Reduced 4.49%	73,716 $1.59 Million
Q2 2019 Aug 15, 2019	BUY	$21.11 - $28.48 $1.63 Million - $2.2 Million	77,185 New	77,185 $1.7 Million

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.34B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History